Drug Development Phase 2
|
Keyword(s)
Drug Development; Clinical Research; Regulatory Affairs; FDA; EMA; Case Study
The Drug Development Phase 2 module is part of the DIA Drug Development and Lifecycle Management eLearning Program. In this module, learners will learn about the factors that drive the design and conduct of phase 2 clinical trials, as well as the activities and functional areas that contribute to a successful phase 2 program.Register Here!
Credit Information
1.25 ACPE
0.1 IACET
1.25 PMI
0.1 IACET
1.25 PMI
Description
FEATURED TOPICS
- Objectives and Key Players
- Regulatory Activities
- Clinical R&D and Biostatistics Activities
- Clinical Study Part 1
- End of Phase 2
- Case Study Part 2
- Review